Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

210.50p
   
  • Change Today:
    -6.00p
  • 52 Week High: 258.00
  • 52 Week Low: 177.20
  • Currency: UK Pounds
  • Shares Issued: 217.41m
  • Volume: 1,110,630
  • Market Cap: £457.65m
  • RiskGrade: 156

Tuesday broker round-up UPDATE

Date: Tuesday 17 Dec 2013

LONDON (ShareCast) - Advanced Medical Solutions: Panmure Gordon downgrades from buy to hold with a target price of 102p.

Antofagasta: Canaccord Genuity cuts target price from 1110p to 1035p, while staying with its buy recommendation.

ASOS: Panmure Gordon increases target price from 5950p to 6126p, while downgrading from buy to hold.

AstraZeneca: Deutsche Bank raises target price from 3425p to 3600p maintaining a hold recommendation.

blur Group: Panmure Gordon ups target price from 677p to 690p and retains a buy recommendation.

British American Tabacco: UBS reduces target price from 3850p to 3715p, while its buy recommendation remains unchanged.

BTG: Deutsche Bank ups target price from 565p to 610p and reiterates its buy recommendation.

Cable & Wireless Communications: Barclays shifts target price from 40p to 43p and retains an equal-weight rating.

Daily Mail & General Trust: Westhouse Securities raises target price from 744p to 864p and maintains a neutral rating.

Daisy Group: Barclays moves target price from 115p to 130p, but downgrades to underweight.

Dixons Retail: Cantor Fitzgerald ups target price from 50p to 60p keeping a buy recommendation. Investec shifts target price from 60p to 62p retaining its buy recommendation.

Europa Oil & Gas: Northland lowers target price from 14.3p to 10.1p leaving its buy recommendation unchanged.

Experian: Jefferies reduces target price from 1200p to 1090p and keeps a hold recommendation.

First Derivates: Panmure Gordon raises target price from 1191p to 1458p and keeps a buy recommendation.

First Group: Goldman Sachs shifts target price from 135p to 140p and retains a buy recommendation.

GlaxoSmithKline: Deutsche Bank reduces target price from 1800p to 1700p while downgrading to hold.

Go-Ahead Group: Goldman Sachs increases target price from 1580p to 2100p and upgrades to a strong buy recommendation.

Imagination Technologies: Barclays cuts target price from 250p to 185p and reiterates an equal-weight rating.

Informa: Canaccord Genuity cuts target price from 600p to 568p downgrading from buy to hold.

Inmarsat: Barclays takes target price from 705p to 740p and keeps an equal-weight rating.

KCOM Group: Barclays moves target price from 100p to 115p retaining its overweight rating.

Sepura: Westhouse Securities upgrades from add to buy with an unchanged target price of 160p.

Stagecoach Group: Goldman Sachs downgrades to sell with a target price of 350p.

Trinity Mirror: Panmure Gordon increases target price from 205p to 300p maintaining a buy recommendation.

UBM: Deutsche Bank moves target price from 830p to 840p retaining a buy recommendation. Westhouse Securities reduces target price from 812p to 755p, while staying with its buy recommendation. Numis cuts target price from 732p to 710p and maintains a hold recommendation. Barclays reduces target price from 810p to 755p, while staying with its overweight rating.

William Hill: Canaccord Genuity lowers target price from 425p to 408p leaving its hold recommendation unaltered.

Wood Group: Canaccord Genuity cuts target price from 875p to 825p and reiterates a hold recommendation.

Xcite Energy: Cantor Fitzgerald shapes target price from 168p to 167p leaving its buy recommendation unchanged.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 210.50p
Change Today -6.00p
% Change -2.77 %
52 Week High 258.00
52 Week Low 177.20
Volume 1,110,630
Shares Issued 217.41m
Market Cap £457.65m
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Price Trend
31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average
Income
86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 2
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 30-May-24 28-Sep-23
Paid 21-Jun-24 27-Oct-23
Amount 1.66p 0.70p

Trades for 17-May-2024

Time Volume / Share Price
16:39 51,000 @ 213.89p
16:39 51,000 @ 214.00p
16:38 50,000 @ 210.15p
16:36 75,000 @ 216.38p
16:35 65,766 @ 210.50p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson
Chair Liz Shanahan

Top of Page